DETAILS, FICTION AND AGO TUMOR

Molecular typing is predicated on molecular genetic tests and is not still routinely readily available. Molecular subtypes and immunohistochemical surrogate markers in the tumors (HR, HER2, triple damaging) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-sixty seven may very w